Chronic inflammatory bowel diseases: Standards and prospects in drug treatment;Chronisch entzüundliche darmerkrankungen: Standards und ausblick in der medikamentösen behandlung

Internist

Volumn 42, Issue 4, 2001, Pages 533-543

  Scholmerich J ^a   Stange, E F ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; PREDNISONE; ANTIINFECTIVE AGENT; GASTROINTESTINAL AGENT;

CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; REVIEW; STANDARD; ULCERATIVE COLITIS; CONTROLLED CLINICAL TRIAL; DIET THERAPY; HOSPITALIZATION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ANTI-INFECTIVE AGENTS; COLITIS, ULCERATIVE; CROHN DISEASE; GASTROINTESTINAL AGENTS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 0035070656     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050788     Document Type: Review

References (47)

1. Safety of azathioprine in pregnancy in inflammatory bowel disease
2. Budesonide versus prednisolone in the treatment of active Crohn's disease
3. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
4. A controlled double blind study of azathioprine in the management of Crohn's disease
5. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis
6. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease
7. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
8. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
9. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis
10. A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
11. Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms
12. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease
13. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease
14. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study
15. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease
16. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis
17. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
18. Selective 5-lipoxygenase inhibition by zileuton in the treatment of relapsing ulcerative colitis: A randomized double-blind placebo-controlled multicentre trial
19. Treatment of fistulizing Crohn's disease
20. Cyclosporine in severe ulcerative colitis refractory to steroid therapy
21. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis
22. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis
23. European cooperative Crohn's disease study (ECCDS): Results of drug treatment
24. Rectal aminosalicylate therapy for distal ulcerative colitis: A meta-analysis
25. Rectal corticosteroids versus alternative treatments in ulcerative colitis: A meta-analysis
26. Adverse events in patients treated with S-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France
27. Frequency of glucocorticoid resistance and dependency in Crohn's disease
28. Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial
29. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial
30. Infliximab for the treatment of fistulas in patients with Crohn's disease
31. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease
32. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
33. A controlled trial of azathioprine in the management of chronic ulcerative colitis
34. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis
35. Transdermal nicotine for mildly to moderately active ulcerative colitis
36. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
37. Future developments in diagnosis and treatment of inflammatory bowel disease
38. Therapie chronischentzündlicher Darmerkrankungen - Colitis ulcerosa und Morbus Crohn
39. Mesalamine capsules for the treatment of active Crohn's disease: Results for a 16-week trial
40. Adverse effects of the aminosalicylates
41. Therapie des Morbus Crohn - Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten
42. Diagnostik und Therapie der Colitis ulcerosa - Ergebnisse einer evidenz-basierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten
43. National cooperative Crohn's disease study: Results of drug treatment
44. Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis
45. Alternatives to sulfasalazine: A meta-analysis of 5-ASA in the treatment of ulcerative colitis
46. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
47. Cortisone in ulcerative colitis. Final report on therapeutic trial